Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-1997 | 09-1996 | 09-1995 | 09-1994 | 09-1993 | |
| Sales | 35,229 | 29,391 | 25,109 | 21,877 | 16,171 |
| Cost of Goods | 12,298 | 8,967 | 8,008 | 7,518 | 5,098 |
| Gross Profit | 22,931 | 20,424 | 17,101 | 14,359 | 11,073 |
| Operating Expenses | 298 | 967 | 10,532 | 10,063 | 7,646 |
| Operating Income | 22,931 | 20,424 | 6,577 | 4,814 | 3,525 |
| Interest Expense | 1,196 | 390 | 1,135 | 1,092 | 179 |
| Other Income | -12,024 | -11,141 | 518 | 262 | -245 |
| Pre-tax Income | 9,711 | 8,893 | 5,960 | 3,984 | 3,101 |
| Income Tax | 3,729 | 3,601 | 2,436 | 1,542 | 1,212 |
| Net Income Continuous | 5,982 | 5,292 | 3,523 | 2,441 | 2,144 |
| Net Income | $5,982 | $5,292 | $3,524 | $2,442 | $1,890 |
| EPS Basic Total Ops | 0.19 | 0.16 | 0.13 | 0.09 | 0.07 |
| EPS Basic Continuous Ops | 0.19 | 0.16 | 0.13 | 0.09 | 0.08 |
| EPS Diluted Total Ops | 0.19 | 0.16 | 0.12 | 0.09 | 0.07 |
| EPS Diluted Continuous Ops | 0.19 | 0.16 | 0.12 | 0.09 | 0.08 |
| EBITDA(a) | $22,931 | $20,424 | $7,440 | $5,517 | $4,106 |